Intentional and non-intentional non-adherence to medication amongst breast cancer patients

被引:193
作者
Atkins, Louise [1 ]
Fallowfield, Lesley [1 ]
机构
[1] Univ Sussex, Canc Res UK, Psychosocial Oncol Grp, Brighton & Sussex Med Sch, Brighton BN1 9QG, E Sussex, England
关键词
breast cancer; patient non-adherence; treatment; intention;
D O I
10.1016/j.ejca.2006.03.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study aimed to investigate the prevalence of and factors associated with non-adherence to medication amongst a sample of breast cancer patients. 131 women with stable disease were interviewed and completed standardised psychological measures. 55% of women reported non-adherence to medication frequently or occasionally, with younger women and those who disliked taking their medication being significantly less adherent (P = 0.015, P = 0.001). Women who deliberately omitted taking their tablets occasionally or frequently had significantly lower scores, indicative of a weaker influence, on 'internal' and 'powerful others' dimensions of health locus of control (P = 0.032, P = 0.009). Despite a life-threatening diagnosis, patients may not adhere to medication representing a potential missed opportunity for health gain and waste of resources. Furthermore, interpretation of clinical trial data may be misleading without adherence information. More research is needed to identify those at risk for non-adherence. If other routes of administration are available these options should be discussed with patients to maximise efficacy of therapy. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2271 / 2276
页数:6
相关论文
共 16 条
  • [1] Adjuvant tamoxifen: Predictors of use, side effects, and discontinuation in older women
    Demissie, S
    Silliman, RA
    Lash, TL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (02) : 322 - 328
  • [2] Doing prescribing: how doctors can be more effective
    Elwyn, G
    Edwards, A
    Britten, N
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2003, 327 (7419): : 864 - 867
  • [3] Patients' preference for administration of endocrine treatments by injection or tablets: results from a study of women with breast cancer
    Fallowfield, L
    Atkins, L
    Catt, S
    Cox, A
    Coxon, C
    Langridge, C
    Morris, R
    Price, M
    [J]. ANNALS OF ONCOLOGY, 2006, 17 (02) : 205 - 210
  • [4] Tamoxifen for the prevention of breast cancer: Psychosocial impact on women participating in two randomized controlled trials
    Fallowfield, L
    Fleissig, A
    Edwards, R
    West, A
    Powles, TJ
    Howell, A
    Cuzick, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (07) : 1885 - 1892
  • [5] Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice
    Farmer, KC
    [J]. CLINICAL THERAPEUTICS, 1999, 21 (06) : 1074 - 1090
  • [6] Tolerability of hormone therapies for breast cancer: How informative are documented symptom profiles in medical notes for 'well-tolerated' treatments?
    Fellowes, D
    Fallowfield, LJ
    Saunders, CM
    Houghton, J
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2001, 66 (01) : 73 - 81
  • [7] Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor-positive breast cancer
    Fink, AK
    Gurwitz, J
    Rakowski, W
    Guadagnoli, E
    Silliman, RA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (16) : 3309 - 3315
  • [8] Adherence beliefs among breast cancer patients taking tamoxifen
    Grunfeld, EA
    Hunter, MS
    Sikka, P
    Mittal, S
    [J]. PATIENT EDUCATION AND COUNSELING, 2005, 59 (01) : 97 - 102
  • [9] Haynes R.B., 1979, COMPLIANCE HEALTHCAR
  • [10] Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness
    Horne, R
    Weinman, J
    [J]. JOURNAL OF PSYCHOSOMATIC RESEARCH, 1999, 47 (06) : 555 - 567